Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor

Compounds of formula (I), are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.

Saved in:
Bibliographic Details
Main Authors GOMTSYAN, ARTHUR R, WHITE, TAMMIE K, KOENIG, JOHN R, DRIZIN, IRENE, SCHMIDT, ROBERT G. JR, BAYBURT, EROL K, TURNER, SEAN C, ZHENG, GUO ZHU, PERNER, RICHARD J, DIDOMENICO, STANLEY JR, LEE, CHIH-HUNG
Format Patent
LanguageChinese
English
Published 01.08.2005
Online AccessGet full text

Cover

Abstract Compounds of formula (I), are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.
AbstractList Compounds of formula (I), are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.
Author GOMTSYAN, ARTHUR R
SCHMIDT, ROBERT G. JR
WHITE, TAMMIE K
LEE, CHIH-HUNG
TURNER, SEAN C
ZHENG, GUO ZHU
DIDOMENICO, STANLEY JR
DRIZIN, IRENE
KOENIG, JOHN R
BAYBURT, EROL K
PERNER, RICHARD J
Author_xml – fullname: GOMTSYAN, ARTHUR R
– fullname: WHITE, TAMMIE K
– fullname: KOENIG, JOHN R
– fullname: DRIZIN, IRENE
– fullname: SCHMIDT, ROBERT G. JR
– fullname: BAYBURT, EROL K
– fullname: TURNER, SEAN C
– fullname: ZHENG, GUO ZHU
– fullname: PERNER, RICHARD J
– fullname: DIDOMENICO, STANLEY JR
– fullname: LEE, CHIH-HUNG
BookMark eNqNyr0KwjAUQOEMOvj3DtdNByFtdegoYnGWomNJbq70QkxCkwj16V3E2ekM35mLifOOZqJtciQD6q0044iWEdA_g8_OREi9SsCuZ80JXsqxtZ4NDIQUkh8gZp3GQFDA5nYttj9YiulD2Uirbxdi3Zzb02VHwXcUg0JylLr2Xkp5KPe1rI_VP88Htck6QQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID TW200524909A
GroupedDBID EVB
ID FETCH-epo_espacenet_TW200524909A3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:28:04 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_TW200524909A3
Notes Application Number: TW20040123414
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050801&DB=EPODOC&CC=TW&NR=200524909A
ParticipantIDs epo_espacenet_TW200524909A
PublicationCentury 2000
PublicationDate 20050801
PublicationDateYYYYMMDD 2005-08-01
PublicationDate_xml – month: 08
  year: 2005
  text: 20050801
  day: 01
PublicationDecade 2000
PublicationYear 2005
RelatedCompanies ABBOTT LABORATORIES
RelatedCompanies_xml – name: ABBOTT LABORATORIES
Score 2.7257888
Snippet Compounds of formula (I), are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder...
SourceID epo
SourceType Open Access Repository
Title Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050801&DB=EPODOC&locale=&CC=TW&NR=200524909A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5qFfWmVdH6YAUJeggmaR7toYhNGorQByW2vZVsNqErJQ1mi9hf72Tpw4velh1Ydgdm5pvZeQA8GAkaHQTqaqhroWraiaNS5lAV9SDCedugmpyf0u3ZnXfzbWJNSvCxqYWRfUK_ZHNElKgI5V1IfZ3tgliezK3MnynHrcWLHzQ9ZeMdI9xA39hrNduDvtd3FddtBmOlN5Q09DS0xuse7COMdgppaI9aRVVK9tuk-CdwMMDTUnEKpdWsAkfuZvJaBQ676w9vXK5lLz-DwF_mMSPhKqQ8-o7wnqTIBy_GIuVEzEJBeDrjlAuC4JjP5wvOCKqzOEOvmuRLWgRbiU4eR0P9aUs4h3u_HbgdFa833fJiGox3L6ldQDldpPElEJNZtYSZtlZnhunEdqOOyCCMEj1JmGUZ2hVU_z6n-h_xGo5lt1KZ83YDZfG5jG_RDgt6Jxn4A2SUjH4
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ZS8NAEB5qFeubVkXrtYIUfQgmaY72oYhNGqr2osS2byGbg66UtJgtYn-9k6WHL_q27MCyOzAz38zOAXCnxmh0EKhLviL7kmbEpkRDk0qoBxHOGyqVxfyUTtdovWuvY32cg491LYzoE_olmiOiRAUo71zo6_k2iGWL3Mr0kTLcmj05bt0ur71jhBvoG9uNerPfs3tW2bLq7qjcHQgaehpy7XkHdhFim5k0NIeNrCpl_tukOIew18fTEn4EueWkCAVrPXmtCPud1Yc3Lleylx6D6yzSKCT-0qcs-A7wniTLB8_GIqWET3xOWDJhlHGC4JhNpzMWElRn0Ry9apIuaBZsJQq5Hw6Uhw3hBG6dpmu1JLyet-GF5462L6mcQj6ZJdEZEC3UK3GoGXI1VDUzMmpVRAZ-ECtxHOq6Kp9D6e9zSv8Rb6DQcjttr_3SfbuAA9G5VOS_XUKefy6iK7TJnF4LZv4AJ7yPcQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Fused+azabicyclic+compounds+that+inhibit+vanilloid+receptor+subtype+1+%28VR1%29+receptor&rft.inventor=GOMTSYAN%2C+ARTHUR+R&rft.inventor=WHITE%2C+TAMMIE+K&rft.inventor=KOENIG%2C+JOHN+R&rft.inventor=DRIZIN%2C+IRENE&rft.inventor=SCHMIDT%2C+ROBERT+G.+JR&rft.inventor=BAYBURT%2C+EROL+K&rft.inventor=TURNER%2C+SEAN+C&rft.inventor=ZHENG%2C+GUO+ZHU&rft.inventor=PERNER%2C+RICHARD+J&rft.inventor=DIDOMENICO%2C+STANLEY+JR&rft.inventor=LEE%2C+CHIH-HUNG&rft.date=2005-08-01&rft.externalDBID=A&rft.externalDocID=TW200524909A